Physician Assistant · Ann Arbor, MI
NPI
1437146297
Since 2005
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1500 E Medical Center Dr
Ann Arbor, MI, 48109
Phone (734) 936-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
303 services
Medicare patients, 2024
110
Average age 71
Drug cost, 2024
$4.8M
813 prescriptions
Company payments, 2025
$1,282
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Heather M Fox was code 99215 (office e&m - established), 106 times for 60 patients. In total Heather M Fox billed 303 services in 7 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-11-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 106 | 60 | $88.00 | $9,328 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 103 | 67 | $10.84 | $1,117 |
| 38222 Other Organ Systems | Facility | 44 | 32 | $48.52 | $2,135 |
| 99214 Office E&M - Established | Facility | 40 | 31 | $62.60 | $2,504 |
By year: 2022 $12K for 171 services; 2023 $17K for 229 services; 2024 $16K for 303 services.
Medicare prescription drug claims, 2024
In 2024, the drug Heather M Fox prescribed most often to Medicare patients was Imatinib Mesylate, with 113 prescriptions and refills. In total Heather M Fox wrote 813 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imatinib Mesylate Generic | 113 | 133 | 16 | $84K |
| Acyclovir Generic | 53 | 147 | 24 | $1,924 |
| Venclexta Venetoclax | 45 | 45 | 18 | $69K |
| Sprycel Dasatinib | 43 | 43 | Under 11 | $696K |
| Levofloxacin Generic | 39 | 40 | 15 | $304 |
| Posaconazole Generic | 37 | 37 | 11 | $48K |
| Tasigna Nilotinib Hcl | 36 | 36 | Under 11 | $421K |
| Bosulif Bosutinib | 33 | 33 | Under 11 | $589K |
| Inqovi Decitabine/Cedazuridine | 31 | 31 | Under 11 | $240K |
| Prochlorperazine Maleate Generic | 28 | 28 | 15 | $394 |
| Iclusig Ponatinib Hcl | 24 | 24 | Under 11 | $521K |
| Hydroxyurea Generic | 24 | 56 | Under 11 | $1,119 |
| Ondansetron Hcl Generic | 24 | 24 | Under 11 | $176 |
| Cyclosporine Modified Cyclosporine, Modified | 21 | 27 | Under 11 | $3,027 |
| Sorafenib Sorafenib Tosylate | 16 | 16 | Under 11 | $77K |
Brand drugs: - claims; generic drugs: 508 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Heather M Fox $1,282 ($1,282 in general payments such as food, travel and fees) from 5 companies. The largest payer was Bard Peripheral Vascular, Inc. with $453.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.